YARW · NASDAQ
Yarrow Bioscience (YARW) Stock Price & Fundamentals
Yarrow Bioscience (YARW) closed at $849.85 on Oct 9, 2026, up 0.61% from the previous close of $844.69.
Share price, past year
1Y +45.72%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $849.85 |
| Sep 30, 2026 | $835.67 |
| Aug 31, 2026 | $839.35 |
| Jul 31, 2026 | $842.38 |
| Jun 30, 2026 | $842.60 |
| May 29, 2026 | $793.35 |
| Apr 30, 2026 | $723.73 |
| Mar 31, 2026 | $720.28 |
| Feb 27, 2026 | $682.39 |
| Jan 30, 2026 | $632.83 |
| Dec 31, 2025 | $636.95 |
| Nov 28, 2025 | $597.96 |
| Oct 31, 2025 | $598.84 |
Key statistics
- Market cap
- $567.98M
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 668.3K
- Dividend yield
- —
- 52-week range
- $583.20 – $861.29
Yarrow Bioscience's market cap is $567.98M, based on a share price of $849.85 and 668.3K shares outstanding as of Jun 30, 2026.
Financials
Yarrow Bioscience reported revenue of $570.00K for fiscal 2025, up 13.77% from fiscal 2024.
Yarrow Bioscience reported a net loss of $26.48M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $570.00K | +13.8% | −$26.48M | −4,646.1% | −$0.62 | — |
| FY2024ended Dec 31, 2024 | $501.00K | +18.2% | −$39.83M | −7,950.9% | −$0.93 | — |
| FY2023ended Dec 31, 2023 | $424.00K | −11.1% | −$28.45M | −6,710.4% | −$2.78 | — |
| FY2022ended Dec 31, 2022 | $477.00K | −48.8% | −$23.21M | −4,865.8% | −$7.28 | — |
| FY2021ended Dec 31, 2021 | $931.00K | −95.6% | −$73.33M | −7,876.4% | −$8,309.03 | −$56.37M |
| FY2020ended Dec 31, 2020 | $20.99M | — | −$255.57M | −1,217.4% | $2,553.63 | −$137.20M |
| FY2019ended Dec 31, 2019 | $0.00 | — | −$95.18M | — | $3,636.01 | −$74.45M |
| FY2018ended Dec 31, 2018 | $0.00 | −100.0% | −$74.16M | — | $3,717.03 | −$69.23M |
| FY2017ended Dec 31, 2017 | $4.58M | +579.8% | −$29.08M | −634.6% | −$1,843.93 | −$28.25M |
| FY2016ended Dec 31, 2016 | $674.00K | — | −$14.07M | −2,087.2% | −$913.86 | −$2.30M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $97.00K | −$3.01M | −$3.51 |
| Q1 FY2026ended Mar 31, 2026 | $86.00K | −$3.59M | −$0.08 |
| Q2 FY2025ended Jun 30, 2025 | $69.00K | −$5.76M | −$6.73 |
| Q1 FY2025ended Mar 31, 2025 | $202.00K | −$8.61M | −$0.20 |
| Q4 FY2024ended Dec 31, 2024 | $84.00K | −$12.02M | −$0.27 |
| Q3 FY2024ended Sep 30, 2024 | $121.00K | −$12.16M | −$0.29 |
| Q2 FY2024ended Jun 30, 2024 | $198.00K | −$9.41M | −$0.22 |
| Q1 FY2024ended Mar 31, 2024 | $98.00K | −$6.25M | −$0.15 |
Company profile
- Name
- Yarrow Bioscience, Inc.
- Ticker
- YARW
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 470 James Street, Suite 007, New Haven, CT 06513
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001566044
Recent SEC filings
- Sep 14, 2026
- Sep 10, 2026
- Aug 13, 2026
- Jul 30, 2026
- Jul 28, 2026
- Jul 21, 2026
- Jul 20, 2026
- Jul 14, 2026
Frequently asked questions
What is Yarrow Bioscience's stock price?
Yarrow Bioscience (YARW) closed at $849.85 on Oct 9, 2026, up 0.61% from the previous close of $844.69.
What is Yarrow Bioscience's market cap?
Yarrow Bioscience's market cap is $567.98M, based on a share price of $849.85 and 668.3K shares outstanding as of Jun 30, 2026.
How much revenue does Yarrow Bioscience make?
Yarrow Bioscience reported revenue of $570.00K for fiscal 2025, up 13.77% from fiscal 2024.
Sources and methodology
Fundamentals come from Yarrow Bioscience, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures